Pulmonx EBITDA Margin 2019-2025 | LUNG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pulmonx (LUNG) over the last 10 years. The current EBITDA margin for Pulmonx as of June 30, 2025 is .
| Pulmonx EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.09B | $-0.06B | -61.54% |
| 2025-03-31 | $0.09B | $-0.06B | -64.77% |
| 2024-12-31 | $0.08B | $-0.06B | -67.86% |
| 2024-09-30 | $0.08B | $-0.06B | -73.42% |
| 2024-06-30 | $0.08B | $-0.06B | -76.62% |
| 2024-03-31 | $0.07B | $-0.06B | -80.82% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -93.85% |
| 2023-06-30 | $0.06B | $-0.06B | -98.36% |
| 2023-03-31 | $0.06B | $-0.06B | -100.00% |
| 2022-12-31 | $0.05B | $-0.06B | -105.56% |
| 2022-09-30 | $0.05B | $-0.06B | -103.77% |
| 2022-06-30 | $0.05B | $-0.05B | -98.08% |
| 2022-03-31 | $0.05B | $-0.05B | -98.00% |
| 2021-12-31 | $0.05B | $-0.05B | -95.83% |
| 2021-09-30 | $0.04B | $-0.04B | -97.73% |
| 2021-06-30 | $0.04B | $-0.04B | -90.48% |
| 2021-03-31 | $0.03B | $-0.04B | -108.82% |
| 2020-12-31 | $0.03B | $-0.03B | -91.18% |
| 2020-06-30 | $0.02B | $-0.02B | -95.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.069B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.530B | 60.47 |
| Tempus AI (TEM) | United States | $13.989B | 0.00 |
| Doximity (DOCS) | United States | $12.688B | 56.45 |
| Hims & Hers Health (HIMS) | United States | $10.074B | 82.54 |
| IRhythm Technologies (IRTC) | United States | $5.433B | 0.00 |
| Hinge Health (HNGE) | United States | $4.491B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.839B | 41.73 |
| Privia Health (PRVA) | United States | $2.699B | 199.91 |
| Heartflow (HTFL) | $2.367B | 0.00 | |
| Enovis (ENOV) | United States | $1.797B | 9.50 |
| 10x Genomics (TXG) | United States | $1.780B | 0.00 |
| Phreesia (PHR) | United States | $1.770B | 0.00 |
| Omnicell (OMCL) | United States | $1.544B | 29.75 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.446B | 63.10 |
| Clover Health Investments (CLOV) | United States | $1.399B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.127B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.580B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.469B | 140.00 |
| Butterfly Network (BFLY) | United States | $0.383B | 0.00 |
| Carlsmed (CARL) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 53.89 |
| Outset Medical (OM) | United States | $0.252B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.231B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.219B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.156B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.120B | 5.44 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.017B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |